Silvis, Suzanne M.
de Sousa, Diana Aguiar
Ferro, José M.
Coutinho, Jonathan M
Article History
First Online: 18 August 2017
Competing interests
: J.M.F. has received personal fees from Boehringer Ingelheim and Daiichi Sankyo. J.M.C. has received research grants for CVT from two non-profit organizations: the Dutch Thrombosis Society and the Netherlands Brain Foundation, and is a steering committee member of the RE-SPECT CVT trial, a clinical trial that evaluates the efficacy and safety of dabigatran for the treatment of CVT sponsored by Boehringer Ingelheim.